Arch Therapeutics Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
ARTH Over the counter 3841 https://www.archtherapeutics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arch Therapeutics Inc

Arch Therapeutics, Inc. to Present at the Virtual Investor Fireside Chat Series - Jun 8th, 2020 11:50 am
Arch Raises $1.4 Million with Convertible Note Issuance and Warrant Reprice - Jun 5th, 2020 9:00 pm
Arch Therapeutics to Provide Corporate Update at the Virtual Summer Summit - Jun 3rd, 2020 1:21 pm
Arch Therapeutics Receives CE Mark Approval for AC5™ Topical Hemostat in Europe - Apr 13th, 2020 12:15 pm
Arch Therapeutics Receives Marketing Clearance from the US FDA Related to the AC5® Topical Gel Supply Chain - Mar 23rd, 2020 11:50 am
Arch Therapeutics, Inc. to Present at the New York City based Investor Summit on March 25th-26th - Mar 18th, 2020 1:00 pm
Arch Therapeutics Novel Self-Assembling Agent for Use in Endoscopic Procedures to be Presented at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2020 Annual Meeting on April 2, 2020 - Mar 4th, 2020 12:50 pm
Arch Therapeutics to Provide Corporate Update at the 2020 LD Micro Virtual Investor Conference - Mar 2nd, 2020 12:50 pm
Arch Therapeutics to Provide Corporate Update at Biotech Showcase™ 2020 on January 13th, 2020 - Jan 8th, 2020 12:50 pm
Arch Therapeutics Announces $2.5 Million Registered Direct Offering - Oct 17th, 2019 12:00 pm
Arch Therapeutics Provides Corporate Update at the 2nd Annual LD Micro Big Apple Conference in Manhattan, NY - Oct 7th, 2019 3:50 pm
Arch Therapeutics to Provide Corporate Update at the H.C. Wainwright 21st Annual Global Investment Conference - Sep 3rd, 2019 11:50 am
Arch Therapeutics Announces AC5 Self-Assembling Peptide Technology Platform Demonstrates Antimicrobial Activity in Two Studies and Provides CE Marking Status Update for AC5™ Topical Hemostat - Aug 5th, 2019 11:50 am